Archives

by in
Entry Author Date Location
Seattle Genetics Gets $138M in First-Year Sales of Cancer Drug 02/12/13 Seattle
Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future 05/08/12 Seattle
Seattle Genetics Gets New Commercial Boss for Early Days of Adcetris 02/23/12 Seattle
Seattle Genetics Sees Updated Side Effect Warning in Drug Label 01/13/12 Seattle
Seattle Genetics: The Next Litmus Test for High Priced Cancer Drugs 08/22/11 National
Seattle Genetics’ FDA Panel Preview: What You Need to Know This Week 07/12/11 Seattle
Seattle Genetics, On the Verge of Going Commercial, Seeks to Keep Its Scientific Soul 07/05/11 Seattle
Dendreon Moves Across Town, SeaGen Files FDA App, Alder Takes Road Less Traveled, & More Seattle Life Sciences News 03/03/11 Seattle
SEC Accuses Seattle Genetics Employee of Insider Trading 01/21/11 Seattle
Seattle Genetics Gets Some Love on National TV, as Cancer Drug Nears Market 01/14/11 Seattle
Editor’s Picks: The Best of 2010 From Xconomy Seattle 12/23/10 Seattle
Seattle Genetics’ Home Run, NanoString’s Diagnostics Foray, PATH’s 50-Cent Vaccine, & More Seattle-Area Life Sciences News 12/09/10 Seattle
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial 12/07/10 Seattle
Seattle Genetics, Millennium Report Groundbreaking Results With Drug for Hodgkin’s 12/05/10 Seattle
Seattle Genetics, Millennium Nail 2nd Straight Trial With “Empowered Antibody” For Cancer 10/11/10 Seattle
Seattle Genetics, Millennium Generate “Dream” Data With Empowered Antibody Drug for Cancer 09/27/10 Seattle
Larry Corey, Virus Hunter With Midwest Roots, Seeks to Unleash Health Innovation at Hutch 08/02/10 Seattle
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News 06/24/10 Seattle
ZymoGenetics Gets Upstaged, Calistoga Cancer Drug Matures, Cramer Replaces Kraemer, & More Seattle-Area Life Sciences News 06/11/10 Seattle
Seattle Genetics Shows Re-Treatment Action 06/05/10 Seattle
Seattle Genetics, Growing Up in a Hurry With Millennium, Aims to Make Most of Cancer Drug 05/26/10 Seattle
Seattle Genetics Adds Patent to 2025 03/11/10 Seattle
Seattle Genetics Starts Lymphoma Trial 02/03/10 Seattle
Accelerator Slowed Down, Inside the Latest Seattle Genetics Deal, Ekos Finds New Use, & More Seattle-Area Life Sciences News 01/28/10 Seattle
Dendreon Recruits Aces to Board, Amgen Seeks to Raise Hit Rate, Lee Hood Startup Gets $30M, & More Seattle-Area Life Sciences News 10/15/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
Seattle Genetics Trial Fills Up 08/24/09 Seattle
Seattle Genetics Gets $136M Total 08/13/09 Seattle
Seattle Genetics, Bucking the Trend, Recruits Hodgkin’s Patients at Warp Speed 08/12/09 Seattle
Seattle Genetics Starts New Trial 06/18/09 Seattle
Page 1 of 2 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.